diabetes

People on Medicare spent $3.4 billion out of pocket last year on the 10 drugs selected Tuesday for Medicare price negotiations. (iStock / Getty Images Plus)

Biden administration chooses first 10 drugs for Medicare price negotiations

BY: - August 30, 2023

WASHINGTON — Medicare can now negotiate lower prices for 10 common high-price drugs, cutting out-of-pocket costs for an estimated 9 million seniors and saving taxpayers billions, the Biden administration said Tuesday. Medicare will begin this year to negotiate with the manufacturers of popular medications used to treat blood clots, diabetes, heart disease, rheumatoid arthritis, chronic […]

COMMENTARY

Not all diabetics are on Medicare, and Congress needs to cap insulin prices for all Americans

BY: - March 8, 2023

For diabetics like me, insulin is as necessary as water, but too often it comes with an unaffordable price tag. As a result, as many as 1 in 4 of the seven million Americans dependent on insulin are skipping or skimping on doses, which can lead to severe complications, including death. Many of us ration doses because of Big […]

As insulin costs soar, diabetics say a $35 cap on co-pays is not enough

BY: - June 15, 2022

WASHINGTON — Lacy Mason was a 21-year-old graduate student in Atlanta when she started rationing her insulin. As a Type 1 diabetic, she needs to take insulin every day for survival. But when the cost surged to $960 a month, Mason could no longer afford it. She had aged out of Medicaid and her student […]

COMMENTARY

COVID-19 is causing more type 1 diabetes in kids, who will be saddled with high insulin prices

BY: - April 14, 2022

As nurses, my husband and I witnessed truly awful and devastating things treating patients on the frontlines of this pandemic. Hundreds of thousands of Americans have died, while the millions who survived, now faced with disability, are left to grapple with the harsh realities of long COVID-19. Among those millions of people living with long-term health impacts […]

$35 insulin cap is welcome, popular, and bipartisan. But Congress may not pass it anyway.

BY: - March 8, 2022

By Michael McAuliff, Kaiser Health News Democrats in the Senate are primed this month to make their first attempt at salvaging one of the most popular elements of President Joe Biden’s stalled Build Back Better plan — the proposal to cap insulin costs at $35 a month. It might not go well. That’s true even […]

Bipartisan senators introduce bill to price cap insulin cost share

BY: - September 2, 2021

A bipartisan pair of state Senators introduced legislation Monday to cap the prices health insurers can charge people with diabetes for their insulin. Senate Bill 220, if passed, would prohibit insurers from charging more than $35 for a 30-day supply of insulin. The bill, less than 100 words in length, could save thousands annually for […]

Ohio Democrats look to wrangle down insulin costs

BY: - February 25, 2020

Democrats in the state House and Senate are pushing legislation that would force insurers to cap patients’ cost-sharing on insulin at $100 for a 30-day supply. The House Health Committee held its first review on the lower chamber’s bill last week, one of several pieces of legislation to address skyrocketing insulin costs in the U.S. […]